All Articles

Why wait? Early combination therapy in diabetic kidney disease: lessons from CONFIDENCE

Finerenone in type 1 diabetes and chronic kidney disease

Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density

Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation

History of gestational diabetes mellitus or hypertensive disorders of pregnancy and risk of chronic kidney disease

Podocyte lipotoxicity in diabetic kidney disease: mechanisms and targets

Immunometabolic drivers of renal fibrosis and potential therapeutic targets in diabetic kidney disease

Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview

Associations of estimated pulse wave velocity with cardiovascular-kidney-metabolic syndrome in U.S. adults: the role of sex and ethnicity (NHANES 1999-2018)

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036

Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

Obesity, kidney and metabolic bariatric surgery: a surgeon's narrative review

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy

PNPLA3 rs738409 polymorphism and kidney dysfunction: an association beyond nonalcoholic fatty liver disease?

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

From liver fat to full-blown metabolic disorder: the kidney as target organ

The Fatty liver Index (FLI) 15 years later: a reappraisal